Publication: The majority of patients with HBeAg-negative chronic hepatitis B treated with peginterferon alpha-2a (40KD) [PEGASYS (R)] sustain responses 2 years post-treatment
Date
Authors
Gürel, Selim
Authors
Marcellin, Patrick
Bonino, Ferruccio
Lau, George
Farci, Patrizia
Yurdaydin, C.
Piratvisuth, Teerha
Jin, R.
Hadziyannis, Stephanos J.
Lu, Zhimeng
Popescu, Madalina
Advisor
Language
Type
Publisher:
Elsevier
Journal Title
Journal ISSN
Volume Title
Abstract
Description
Bu çalışma, 26-30 Nisan 2006 tarihleri arasında Vienna[Avusturya]’da düzenlenen 41. Annual Meeting of the European-Association-for-the-Study-of-the-Liver’da bildiri olarak sunulmuştur.
Source:
Keywords:
Keywords
Gastroenterology & hepatology
Citation
Marcellin, P. vd. (2006). ''The majority of patients with HBeAg-negative chronic hepatitis B treated with peginterferon alpha-2a (40KD) [PEGASYS (R)] sustain responses 2 years post-treatment''. Journal of hepatology, 44(Suplement 2), S275-S275.